Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
